Cargando…
Cytokine polymorphisms influence treatment outcomes in SLE patients treated with antimalarial drugs
Antimalarial agents have been widely used as disease-modifying antirheumatic drugs in the treatment of systemic lupus erythematosus (SLE) and other rheumatological diseases, although their mechanism of action has not yet been fully defined. It is known, however, that effective response to treatment...
| Autores principales: | , , , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2006
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1526590/ https://www.ncbi.nlm.nih.gov/pubmed/16507146 http://dx.doi.org/10.1186/ar1897 |